Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Vivimed Labs

BSE: 532660|NSE: VIVIMEDLAB|ISIN: INE526G01021|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 17, 15:49
115.05
-0.6 (-0.52%)
VOLUME 68,738
LIVE
NSE
Nov 17, 15:55
115.15
-0.6 (-0.52%)
VOLUME 665,953
Announcements on Vivimed Labs

16th-Nov-2017 12:14Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

16th-Nov-2017 11:54Source: BSE

Vivimed Labs- Analyst / Investor Meet - Intimation

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be attending the fol...

15th-Nov-2017 15:15Source: BSE

Vivimed Labs- Investor Presentation

Investor Presentation Q2FY18

14th-Nov-2017 19:48Source: BSE

Vivimed Labs- Analyst / Investor Meet - Intimation

Intimation for conference call with analysts/investors post announcement of Q2 & H1 FY18 results.

14th-Nov-2017 19:24Source: BSE

Vivimed Labs- Financial Results For Period Ending 30.09.2017

The Board of Directors of the Company at its meeting held on November 14, 2017 inter alia, have approved / resolved/ taken note of the following:

1. Pursuant to Regulation 33 of the Securitie...

8th-Nov-2017 18:07Source: BSE

Vivimed Labs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kiran Vyapar Ltd

6th-Nov-2017 09:00Source: BSE

Vivimed Labs- Notice Of Board Meeting For Considering Unaudited Financial Results For The Quarter And Half Year Ended 30/09/2017 & Closure Of Trading Window - Reg

With reference to the captioned subject, this is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, November 14, 2017, inter alia, to consider and approve t...

3rd-Nov-2017 16:19Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has informed the Exchange regarding allotment of 537500 Equity Shares under ESOP

3rd-Nov-2017 15:46Source: BSE

Vivimed Labs- Allotment of ESOP / ESPS

We wish to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company through a resolution passed at its meeting held on 3rd November, 2017, has allotted 5,37,5...

24th-Oct-2017 16:22Source: BSE

Vivimed Labs- CERTIFICATE UNDER REGULATION 40 (9)OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE HALF YEAR ENDED SEPTEMBER 2017

I have examined all Share Transfer deeds, Memorandum of Transfers, Registers, Files and other Documents relating to M/s. VIVIMED LABS LIMITED maintained by M/s.Aarthi Consultants Pvt. Ltd., for the pe...

1 2 3 4 5 Next >>
Quick Links for Vivimed Labs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.